COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Stelexis Therapeutics is a New York–based cancer therapeutics firm using a proprietary drug-discovery platform to identify and selectively target pre-cancerous stem and progenitor cells driving hematopoietic and solid tumor recurrence.